Skip to results
Modify your search
NARROW
1-20 of 22
Authors: Jingqin Luo
Journal Article
CTIM-23. A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) AND EPACADOSTAT (IDO1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295 Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii90, https://doi.org/10.1093/neuonc/noae165.0356
Published: 11 November 2024
Journal Article
CTIM-30. NT-I7, A LONG-ACTING INTERLEUKIN-7, PROMOTES ACTIVATION, CYTOTOXIC FUNCTION, AND SELECTIVE CLONOTYPE EXPANSION OF CD8+ T CELLS IN PATIENTS WITH HIGH GRADE GLIOMAS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi.org/10.1093/neuonc/noae165.0363
Published: 11 November 2024
Journal Article
EPCO-44. SPATIAL TRANSCRIPTOMICS ENABLES STATISTICAL MODELING OF SEX DIFFERENCE IN GENE CO-EXPRESSION NETWORK AND IMMUNE LANDSCAPE OF GLIOBLASTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii11–viii12, https://doi.org/10.1093/neuonc/noae165.0043
Published: 11 November 2024
Journal Article
IMMU-28. TREM2 INHIBITION REPROGRAMS MYELOID CELLS TO STIMULATE ANTI-TUMOR IMMUNITY THROUGH BOTH DIRECT AND INDIRECT MECHANISMS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v148, https://doi.org/10.1093/neuonc/noad179.0560
Published: 10 November 2023
Journal Article
CSIG-10. SEX-DIFFERENCES IN NF-ΚB SIGNALING DRIVE SEX-BIASED RESPONSES TOWARDS SENESCENCE AND INFLAMMATION IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v42, https://doi.org/10.1093/neuonc/noad179.0166
Published: 10 November 2023
Journal Article
Characterization of cell-type specific circular RNAs associated with colorectal cancer metastasis Open Access
in
NAR Cancer
NAR Cancer, Volume 5, Issue 2, June 2023, zcad021, https://doi.org/10.1093/narcan/zcad021
Published: 19 May 2023
Journal Article
Diffusion basis spectrum imaging as an adjunct to conventional MRI leads to earlier diagnosis of high-grade glioma tumor progression versus treatment effect Open Access
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad050, https://doi.org/10.1093/noajnl/vdad050
Published: 19 April 2023
Journal Article
CTIM-10. A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295 Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii61, https://doi.org/10.1093/neuonc/noac209.242
Published: 14 November 2022
Journal Article
IMMU-35. TREM2 RESTRAINS ANTI-TUMOR CELL ACTIVITY OF MYELOID CELLS IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii138–vii139, https://doi.org/10.1093/neuonc/noac209.532
Published: 14 November 2022
Journal Article
Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan Free
in
Brain
Brain, Volume 145, Issue 12, December 2022, Pages 4459–4473, https://doi.org/10.1093/brain/awac238
Published: 04 August 2022
Journal Article
EDITOR'S CHOICE
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma Free
Neuro-Oncology Practice, Volume 9, Issue 3, June 2022, Pages 193–200, https://doi.org/10.1093/nop/npac003
Published: 31 January 2022
Journal Article
Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma Open Access
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac002, https://doi.org/10.1093/noajnl/vdac002
Published: 10 January 2022
Journal Article
CTIM-07. A PHASE I/II STUDY EVALUATING THE SAFETY AND EFFICACY OF A NOVEL LONG-ACTING INTERLEUKIN-7, NT-I7, FOR PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS AFTER CHEMORADIOTHERAPY Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi50, https://doi.org/10.1093/neuonc/noab196.199
Published: 12 November 2021
Journal Article
Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study Open Access
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab041, https://doi.org/10.1093/noajnl/vdab041
Published: 02 March 2021
Journal Article
A MicroRNA Expression Signature as Prognostic Marker for Oropharyngeal Squamous Cell Carcinoma Free
JNCI: Journal of the National Cancer Institute, Volume 113, Issue 6, June 2021, Pages 752–759, https://doi.org/10.1093/jnci/djaa161
Published: 15 October 2020
Journal Article
β–III-spectrin immunohistochemistry as a potential diagnostic tool with high sensitivity for malignant peripheral nerve sheath tumors Free
Neuro-Oncology, Volume 20, Issue 6, June 2018, Pages 858–860, https://doi.org/10.1093/neuonc/noy038
Published: 27 March 2018
Journal Article
A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy Free
The Oncologist, Volume 23, Issue 7, July 2018, Pages 760–e76, https://doi.org/10.1634/theoncologist.2017-0536
Published: 27 February 2018
Journal Article
CSIG-20. IDENTIFICATION OF A NAMPT-E2F2-ID1 SIGNALING AXIS IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi45, https://doi.org/10.1093/neuonc/now212.181
Published: 07 November 2016
Journal Article
METB-05. IDENTIFICATION OF A PROGNOSTIC SEXUAL DIMORPHISM IN GLIOMA GLYCOLYSIS Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi100–vi101, https://doi.org/10.1093/neuonc/now212.419
Published: 07 November 2016
Journal Article
MPTH-39. SEX-SPECIFIC ANALYSIS OF GBM TRANSCRIPTOMES REVEALS NEW PROGNOSTICALLY IMPORTANT MOLECULAR SUBTYPES Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi114, https://doi.org/10.1093/neuonc/now212.476
Published: 07 November 2016
